Advanced Medical Solutions Grp PLC Director/PDMR Shareholding (8282B)
April 06 2017 - 8:23AM
UK Regulatory
TIDMAMS
RNS Number : 8282B
Advanced Medical Solutions Grp PLC
06 April 2017
5 April 2017
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a
leading developer and manufacturer of advanced products for the
global surgical and advanced wound care markets, announces that it
was notified on 4 April 2017 that on the same day, Chris Meredith,
who is a Director and PDMR, had transferred 5,900 Ordinary Shares
of 5p held in the name of Platform Securities Nominees Limited
("Nominee") to a self-invested personal pension ("SIPP") held in
his name.
The Company was also informed at the same time, that on 4 April
2017 Chris Meredith had transferred 4,780 Ordinary Shares of 5p
held in the name of the Nominee to an Individual Savings Account
("ISA") held in the name of Ingrid Meredith, the wife of Chris
Meredith. The number of shares held by Chris Meredith and the
beneficial ownership of the shares remains unchanged. Both
transactions are part of normalised tax planning. The transfers are
summarised below:
Director Number Price Number Price Number Price
of Ordinary per of Ordinary paid of Ordinary paid
Shares Ordinary Shares per Ordinary Shares per Ordinary
sold Share purchased Share purchased Share
from sold by SIPP by SIPP by ISA by ISA
Nominee
----------- ------------- ---------- ------------- -------------- ------------- --------------
Chris
Meredith 5,900 249.25p 5,900 249.50p - -
----------- ------------- ---------- ------------- -------------- ------------- --------------
Chris
Meredith 4,780 249.25p - - 4,780 249.50p
----------- ------------- ---------- ------------- -------------- ------------- --------------
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Chris Meredith
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Director/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transactions:
* Transfer of 5,900 Ordinary Shares of 5p held in the
name the Nominee to a SIPP held in the name of Chris
Meredith
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
---------------- ----------
Sale of shares
from Nominee
holding at
249.25p per
share 5,900
---------------- ----------
Purchase
by SIPP at
249.50p per
share 5,900
---------------- ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 5,900
Aggregated price: 249.25p
--- ---------------------------------------------------------------
e) Date of the transaction: 04/04/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ----------------------------------------------------------------
a) Name: Chris Meredith
--- ----------------------------------------------------------------
2. Reason for the notification
--- ----------------------------------------------------------------
a) Position/status: Director/PDMR
--- ----------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ----------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ----------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ----------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ----------------------------------------------------------------
b) Nature of the transactions:
* Transfer of 4,780 Ordinary Shares of 5p held in the
name the Nominee to an ISA held in the name of Ingrid
Meredith
--- ----------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
---------------- ----------
Sale of shares
from Nominee
holding at
249.25p per
share 4,780
---------------- ----------
Purchase
by ISA at
249.50p per
share 4,780
---------------- ----------
--- ----------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 4,780
Aggregated price: 249.25p
--- ----------------------------------------------------------------
e) Date of the transaction: 04/04/2017
--- ----------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ----------------------------------------------------------------
- End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Chief Financial
Officer
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Jonathan AMS@consilium-comms.com
Birt / Matthew Neal / Hendrik
Thys
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Patrick Robb
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical and advanced wound care markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
wound care products that include silver alginates, alginates,
foams, tissue adhesives, sutures and haemostats, which it sells
under white label as well as its own brand ActivHeal(R) , and
surgical tissue adhesives, sutures and haemostats, which markets
under its own brands; LiquiBand(R) and RESORBA(R) .
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 70 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Company has 600 employees. For more
information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBDGDSDDGBGRL
(END) Dow Jones Newswires
April 06, 2017 08:23 ET (12:23 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024
